Visby Medical近日宣布与Quest Diagnostics及徕博科达成合作，旨在拓宽消费者对首款经美国FDA授权的家用性传播感染PCR检测产品的获取渠道。此次合作将整合三方资源，通过专业实验室网络与零售渠道的协同效应，让用户能够更便捷地获得这款突破性的自我采集检测工具。该检测技术采用PCR方法，具备实验室级别的准确度，同时保障用户隐私与检测便利性，标志着居家医疗检测领域的重要进展。
Visby Medical近日宣布与Quest Diagnostics及徕博科达成合作，旨在拓宽消费者对首款经美国FDA授权的家用性传播感染PCR检测产品的获取渠道。此次合作将整合三方资源，通过专业实验室网络与零售渠道的协同效应，让用户能够更便捷地获得这款突破性的自我采集检测工具。该检测技术采用PCR方法，具备实验室级别的准确度，同时保障用户隐私与检测便利性，标志着居家医疗检测领域的重要进展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.